alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Page 1 of 3

Disposition Comments

Docket No: FAA-2013-0597 These comments are in

Directorate ID: 2013-CE-016-AD response to an SNPRM

Originating Office Tracking No.: 

Next Step: FRAN SNPRM

 No Comments/Only Supportive Comments Received – If this box is checked, no signatures are 

required.

No Has the referenced service information been revised since the NPRM was issued? If yes, 

list latest revision and attach a copy. Note that changes beyond the scope of the previously 

published NPRM will require a new notice. Contact the Directorate focal point for guidance.

Instructions: Summarize all comments by issue (not by commenter) and provide your recommended resolution of 

each issue. All comments relating to the same issue should be discussed together. Do not list all of the issues 

from one commenter together. If changes to the AD are required based on the comments received, explain why and 

describe in detail what change(s) you recommend. Reference FAA-IR-M-8040.1C Chapter 9.

ISSUE 1: Select one of the following: 

If other, explain: 

Commenter(s): 

What change to the AD action is requested? 

Why is the change requested or how is it justified? 

Do we agree? 

If YES, we agree because Make the following changes to the AD: 

If PARTIALLY AGREE, we agree with because We disagree with because 

Make the following changes to the AD: 

If NO, we don’t agree because 

ISSUE 2: Select one of the following: 

If other, explain: 

Commenter(s): 

What change to the AD action is requested? 

Why is the change requested or how is it justified? 

Do we agree? 

If YES, we agree because Make the following changes to the AD: 

If PARTIALLY AGREE, we agree with because We disagree with because 

Make the following changes to the AD:
Page 2 of 3

If NO, we don’t agree because 

For additional issues, double-click here
Page 3 of 3

Signature Section

Signature indicates concurrence with this action.

Originating Office Tracking No.: 

ASE Printed Name: Date

Branch Manager Date
United States Court of Appeals

for the Fifth Circuit

No. 19-60674

Summary Calendar

Maria Mercedes Gomez-De Saravia, 

Petitioner,

versus

Merrick Garland, U.S. Attorney General, 

Respondent.

Petition for Review of an Order of the

Board of Immigration Appeals

BIA No. A208 538 949

Before Davis, Stewart, and Dennis, Circuit Judges.

Per Curiam:*

Maria Mercedes Gomez-De Saravia petitions for review of a Board of 

Immigration Appeals (BIA) decision denying her motion to reopen. She 

argues that a recent Supreme Court case, Pereira v. Sessions, 138 S. Ct. 2105 

(2018), necessitates reopening and termination of her removal proceedings 

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

April 20, 2021

Lyle W. Cayce

Clerk

Case: 19-60674 Document: 00515828675 Page: 1 Date Filed: 04/20/2021
No. 19-60674

2

and, alternatively, that Pereira renders her eligible for post-conclusion 

voluntary departure and thus the time and number limitations associated 

with motions to reopen should be equitably tolled. Here, the BIA denied the 

motion to reopen as time and number barred. Alternatively, the BIA held 

that on the merits Pereira did not apply to Gomez-De Saravia’s case. We do 

not address Gomez-De Saravia’s argument that the 90-day period for filing a 

motion to reopen should have been equitably tolled.

This court reviews an immigration court’s denial of a motion to 

reopen removal proceedings “under a highly deferential abuse-of-discretion 

standard.” Garcia-Nuñez v. Sessions, 882 F.3d 499, 505 (5th Cir. 2018). We 

find that Gomez-De Saravia’s arguments regarding Pereira are precluded by 

our precedent. Pierre-Paul v. Barr, 930 F.3d 684, 689-90 (5th Cir. 2019), cert. 

denied, 140 S. Ct. 2718 (2020); see also Mauricio-Benitez, v. Sessions, 908 F.3d 

144, 148 n.1 (5th Cir. 2018). Her arguments do not concern the stop time 

rule and so her case was not changed by the decision in Pereira. Id.

We lack jurisdiction to consider Gomez-De Saravia’s argument 

concerning the BIA’s sua sponte authority. See Mendias-Mendoza v. Sessions, 

877 F.3d 223, 227 (5th Cir. 2017). 

AFFIRMED in part; DISMISSED in part.

Case: 19-60674 Document: 00515828675 Page: 2 Date Filed: 04/20/2021
<PAGE>

                           MAFCO CONSOLIDATED GROUP
                             LIST OF SUBSIDIARIES
                            AS OF FEBRUARY 28, 1997

<TABLE>
<CAPTION>
                         COMPANY NAME                               STATE OF INCORPORATION
----------------------------------------------------------------   --------------------------
<S>                                                                <C>
Consolidated Cigar Holdings Inc.                                   Delaware (DE)
Consolidated Cigar Corporation                                     DE
Jamaica Tobacco Manufacturing Company (1995) Limited               Jamaica
Triple C Marketing Inc.                                            DE
Tobacos San Andres S.A. de C.V.                                    Honduras
Congar International Corporation                                   DE
Tabacalera De Garcia, Ltd.                                         Bermuda
Cuban Cigar Brands, NV                                             Netherlands-Antilles
Direct Products Inc.                                               DE
MCG Intermediate Holdings Inc.                                     DE
PA Abex Acquisition Limited                                        Canada
PA Abex Acquisition Canada Inc.                                    Canada
New Abco Holdings Inc.                                             DE
Henley Shareholder Services Inc.                                   DE
Henley Residence Inc.                                              DE
Liberty Lane Real Estate, Inc.                                     DE
Newco K.M.R. Corporation                                           Florida
Pershing Park, Inc.                                                DE
Garden City Fan of Canada Limited                                  Canada
Garden City Fan & Blower De Mexico S.A. de D.V.                    Mexico
SCSA, Inc.                                                         DE
Cleveco Inc.                                                       DE
Abco Canada Holdings Inc.                                          DE
PA Defense Systems Inc.                                            DE
PA Partners, L.P.                                                  DE
Power Control Technologies Inc. (28.7% owned)                      DE


</TABLE>




                                  Exhibit 21
##### 



Exhibit 32.1
 CERTIFICATION WITH RESPECT TO
ANNUAL REPORT OF
HCC INSURANCE HOLDINGS, INC.
  1.
    
    that the Report fully complies with all requirements of Section 13(a) and 15(d) of the
Securities Exchange Act of 1934, as amended; and2.
    
    that the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company as of and for the periods
presented in the Report.
 March 15, 2006
    
    
    
    /s/ Stephen L. Way(Date)
    
    
    
    Stephen L. Way, Chairman of the Board,Chief Executive Officer and PresidentMarch 15, 2006
    
    
    
    /s/ Edward H. Ellis, Jr.(Date)
    
    
    
    Edward H. Ellis, Jr., Executive Vice President andChief Financial Officer
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 219 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 219

  To prohibit the expenditure of Federal funds for abortions, and for 
                            other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 21, 2015

   Mr. Casey introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
  To prohibit the expenditure of Federal funds for abortions, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hyde Amendment Codification Act''.

SEC. 2. PROHIBITING FEDERALLY FUNDED ABORTIONS.

    Title 1 of the United States Code is amended by adding at the end 
the following new chapter:

          ``CHAPTER 4--PROHIBITING FEDERALLY FUNDED ABORTIONS

``SEC. 301. PROHIBITION ON FUNDING FOR ABORTIONS.

    ``(a) In General.--No funds authorized or appropriated by Federal 
law, and none of the funds in any trust fund to which funds are 
authorized or appropriated by Federal law, shall be expended for any 
abortion.
    ``(b) Health Benefits Coverage.--No funds authorized or 
appropriated by Federal law, and none of the funds in any trust fund to 
which funds are authorized or appropriated by Federal law, shall be 
expended for health benefits coverage that includes coverage of 
abortion.

``SEC. 302. TREATMENT OF ABORTIONS RELATED TO RAPE, INCEST, OR 
              PRESERVING THE LIFE OF THE MOTHER.

    ``The limitations established in sections 301 shall not apply to an 
abortion--
            ``(1) if the pregnancy is the result of an act of rape or 
        incest; or
            ``(2) in the case where a woman suffers from a physical 
        disorder, physical injury, or physical illness, including a 
        life-endangering physical condition caused by or arising from 
        the pregnancy itself, that would, as certified by a physician, 
        place the woman in danger of death unless an abortion is 
        performed.''.
                                 <all>
```
Exhibit 21

                                   Foamex L.P.
                           Foamex Capital Corporation
                           SUBSIDIARIES OF REGISTRANTS
                              as of January 2, 2005


                                                     State or Other Jurisdiction
Subsidiaries                                         of Incorporation

Espumas Foamex Espana, S.L.                          Spain
Foamex Asia, Inc.                                    Delaware
Foamex Canada Inc.                                   Canada
Foamex Carpet Cushion LLC                            Delaware
Foamex de Acuna, S.A. de C.V.                        Mexico
Foamex de Mexico, S.A. de C.V.                       Mexico
Foamex de Cuautitlan, S.A. de C.V.                   Mexico
Foamex de Juarez, S.A. de C.V.                       Mexico
Foamex Latin America, Inc.                           Delaware
Foamex Mexico, Inc.                                  Delaware
Foamex Mexico II, Inc.                               Delaware
Grupo Foamex de Mexico, S.A. de C.V.                 Mexico
Servicios Administrativos Foamex, S.A. de C.V.       Mexico
Maquila Foamex, S.A. de C.V.                         Mexico
Corte y Costura Foamex, S.A. de C.V.                 Mexico
Administration Foamex, S.A. de C.V.                  Mexico
Effective  May  6,  1999,  Foxmoor  Industries,  Ltd.  ("Foxmoor"  or  "the
Company")  finalized a  settlement  of all claims by Foxmoor  against its former
independent  auditors,  John M.  Hanson &  Company,  P.C.  and past and  present
members of that firm ("Hanson").  Foxmoor's claims against Hanson arose from the
audits  performed by Hanson of the Company's  financial  statements  for several
years through fiscal year 1996.  Hanson has vigorously  denied  Foxmoor's claims
and  denied  any  liability  to Foxmoor  or its  stockholders.  Pursuant  to the
settlement,  Foxmoor is to receive  $999,999.  Foxmoor and Hanson have concluded
that the settlement is in the best interests of both Foxmoor and Hanson. Foxmoor
has  concluded  that further  litigation  of the claims  against  Hanson and its
members would be unjustified, and that the settlement is in the best interest of
Foxmoor. The Company is continuing to purse its claims against other persons and
entities including its former president, Mr. W. Ross C. Corace.
\ 

·, 

. ~-

::·.'i, .· 

.... 

Ja ,.,_. \o Ute ot'fioSal lilts or Jin,.._ 11 

l.fJ8 ~ i•,... aa toUouat 

AM tM ola1a1. 

,,,(.. fte ~ ill & ~htc lUObUw f~ 

.... ptt9Pbwud tied..,._ ... ,,., • .- eatspr!~ng a 8mea of 

"ta.pt 1'!heel.e:·ror'w!u. ~. - • upe'u.t . a atr~ ~ . 

..,..._..,, ....i.1 oyien.u t.o ee1phtr and tor df.141rMr ,., ........ 

., a i:-laia 1..,.219_....,, oat.. ~,.~at~ l';hGf'l t.l\e .,.,- •11111 

--~ ie Nf*'hd. lNMsk. J.ato the ftllllhtM it OOllUlfl i;;ttt. _.. 

... \'f l!111 • 

,_., "l•, -... "1• r.er«in ie •W•••l•• ,,_,. _ _. \• IJ"'.)wda ot reJ•10a, t.htl tin\ flf 

au ., t.ho arr,,,.._ •ltttu Mnt.otoft ..,.S.\ted a.re ~"*19 

w al.l.ow&hls. ,._. an •~ 6Pr••u• cla1• Md 

ee11' tdnti utJao4 eJ.aliite •.. Oert&inl,r nliw ..u.4. o~-. 

J•d•s1'bl• wt.• ... ,..,.. twnty-i:;lsh\ all•abl.e a~tua 

Declassified and approved for release by NSA on 09-13-2013 pursuantto E .0. 1352a 

SECRET 
·' • 

el*'N. 1\ ... wi\.boat ll&7iDg t,h&t. met.bod and &} pan.tu 

claim• are 1D 4Ut_._t .w.t.lltor,y clas ... anct one doea not. 

Benco, 1t 11 ah~plJ' necesaar.r t.o ""iw th• •t.1104 

claima. In ttiia ~ction. tho --.s..r i• ~ to 

reoomaU_. hi.a reJect.ioa in the u.pt. of \be tollowirJ.g dGciaiona 

Ix parte liu-nt.t and Udell 26 OOl"Q lSO. 

Willi• u. Hill 

Auociate Att,or.197 tor Applicant.
REF ID:A65968 

lerb.lt o<f0S --

Mr. John Cw WcPhcraon 

Viee Pft11d.ent 

lntern'l.tiom..1 !:uaioese Ml.chines Corp. '90 ~ieon ATitr:1U4 

W.V Yark 22,. 1'l1v l' ork 

Dear J'obn • 

1 5 APR 1954 

'the mxt ..ting at t~ 1'3.tioml Securit,y Aq::.ncy Scientific 

Advtaary Jo&.rcl vlll "PJD at lOtOO a.a. on Tue~, 20 April 1954, 

1.1\ the Sta.ft Conrerencf) Room (l9--232B) at the lavul Security Sta.t1on, 

Wubi.ngton. 

tar the 

Inalosed. 

tvo-day 

tor 

etttta1on. 

.,au:r 1nt'ot7int1on 

Your attention 

le • copy 

ta co.lled 

qt the 

to 

proposed 

tTMt ite!'l ~ on 

the Oryptol.ogie lqui~nt Piulol. SU.Ce thie va.e -.a item ct ao.10 

.U.c::u.esion at the ls.at JJSASAB .atina, and. ·~ you ue Chairann 

t4 th::lt Panel, ~· • hv wot'd..e from you on 1ts eetabl1ehment and 

tunctiona vauld be ot conaiderable 1.nteraat to all the other memwre 

O'f" JISASAB. 

Your letter of 7 April 1954 vith reference to t1- Iti4 translation 

prQiP.'a.s tor the 701, I lM.nled. t'ror.t our Mr. 8nyd.or bet'ore yau:r latter 

came tb&.t w bad al:tllady the 1'--netit ot certe.ifl ca.rda am dat.a m.f bt:l.d 

prepared but .t have uked hi.tit to go into thl• -.tter iJl d.etall penonal ... 

l,y .ria an •ure ve 'knov' -11 we •houl.d k::ccnr e.bout the ~lation ayatem 

aD1 the 701. !le pl.t.JUJ .. t.l'ip to talk vith :your Mr. Sheridan and othen 

on thie project. 

'1'bank JOU alao tar aterding - the copy or the .Mn•a by Dr. Bush. 

? thougbt it ll08t intereatillg ,.. a eoncile, rorcotul, &Cd extremely eln-evd. 

}ticture ot our preaent national •it\lation in rase3rch .m. ~lopcient 

•tton. 

I ut look1na torlal'd to aeoine rou ~t th& eaot1:og m 20 April .. 

Incl. 

cc: AG 

c/s 

WILLIA.M 'I'.. J'RlEI:t!Alt 

heeutive Secret.arr 

leA Scient1!'ie Mvhory ~ 

S/ASST (Mr. Fried.nan) 

M/R: Notitiea Board ~rribers on next NSASAB ~eting. Requests Mr. McPherson 

to brief' '.Board on Cryptologic Equipment Panel. Ref'era to IBM translation 

program for the 701. 

Lt. I.T. McDONALD/6o493/12 Apr 54/can 

@'pproved for Release by NSA on 07-23-2014 pursuantto E.O. 1352a
• REF ID_:A70CW: 

~ 

COLONEL HUGH ERSKINE, MR. WILLIAM F. FRIEDMAN 

S.I.8., Base 3, 3932 MILITARY ROAD, .ff. W. . . 

A.P.O. 923, ~ Postmaster; 

San Francisco, Cal1forn1a. ·WASHINGTON 15, D. C. 

23 MARCH 1945. 

DEAR HUGH: - . I WAS VERY HAPPY TO RECEIVE YOUR INTERESTING U:TTER OF 

24 FEBRUARY, TOGETHER WITH THE' POCKETBOOK CONTAINING THE STORY 

BY HEX STOUT. I HAD NEVER ENCOUNTERED THIS VERY AMUSING BIT 

OF RESEARCH AND I AM EXTREMELY WELL PLEASED. TO HAVE IT. NO 

DOUBT I WILL BE ABLE TO USE THE ITEM EFFECTIVELY IN SOME SKIT 

CONCERNING THE SHA!ESPEAHE-BACON·CIPBERS. 

I AM SURE THAT WE ALL ENJOYED YOUR VISIT VERY .MUCH AND 

WE.WERE VERY HAPPY TO HAVE YOU WITH US EVEN THOUGH IT WAS FOR 

ONLY SO SHORT A TIME. 

THE MOVING WHICH ·you EXPECTED· TO·DO SHOULD BE OVER BY 

THIS TIME AND I HOPE EVERYTHING IS GOING FORWARD IN ACCORDANCE 

WITH BEST EXPECTATIONS. · 

PLEASE GIVE MY VERY BEST TO EVERYBODY AND TELL THEM 

I HOPE TO SEE -THEM SOME TIME IN THE FUTURE• -

.I AM 

WITH MANY THANKS FOR THE BOOK AND CORD~L OREETI>:'GS, 

SINCEl_mLY '· 

WILLIAM F. FRIEDMAN. 

@'pproved for Release by NSA on 0~-24-2014 pursuantto E.O. 1352a 
REF ID:A78ll82 ~ 

---------- ------~ SEClli.:r C Olifli' IDElfi' IAL RESTiUCI'ED 

.!'.£ -DATE1 M~ F10'M 

:L.nnnanding .11.ssistar:.t Cor.t':l.B.ndant ~----~'----- ------. ----.~----,.-- Dir of Comm Research ,, ----Control 0 ---------

Fiscal 0 -----Administ_r_a_t_i_v_e __ O _____________ _ 

Post Adjmtant 

Int e 11 i gen c e ..,,---------------- 0 

~ r o v o st Marshal -----------------

---------------- 2nd Sig Serv Bn __,,,...,..... _________ __ Chief 1 Pers .& Tng Div ---- Chief, Pers Br ------

Chief, Tng Br 

O/C Officer Pers Sec 

Chief, Oper Serv Jiv ------ ---- Chief, ---------- Co:nr:lunications Br ----- C~ief, Laboratory Br ------- Chief, i.!achine Br -------------- Chief 1 Suppl~{ Br 

O/C, SSA "i~ia i1 Un""'i"""t------------

Chief, Security Div ----- ------------- Chief, Protective Sec Br ----- Chief, Cryptographic Br 

Chief, Devolcpm.ent Br ---- Chief, Intelligence Div ------ ----- Chief, Language Br _.,,.__,,...,.....__,,, ------ __ _ Chief, ~~il Cryptanalytic Br 

Chief, Gen Cryptanalytic Dr 

Chief 1 T/A and Control Br ...---

Chief, I & L Br ---------------

As discussed 

As requested .-----------------

0 P lJ!f.1. e !l ts and ------------------ return !formation and fil_e ________ _ 

ni'or:r.a t ion and fo!";;ardini; 

f'or:nation and return ---

Reco:i"'.lenda. tion See note on re_v_e_r_s_e __________ __ 

SiLnature if app~oved 

Your ~ction -----

~ {Je.g~~~? 

/..~JU/./~~ ~~a.~ ,-

srsac Form ii.~ (~ev . · 

16 :Nov 44 


-~· "'. 

•. . . 

7 ~ 

-· _,. . . . . . . . .· ·: .. 

. ·. 

. ... 

·-

.· 

. '
SAT Report

PMN Number: P-13-0055

SAT Date: 11/14/2012

Print Date: 3/4/2013

Related cases:

Health related cases: 

Ecotox related cases: 

Concern levels:

Type of Concern: Health Eco Comments

Level of Concern: 2 3

 Persistence Bioaccum Toxicity Comments

1 12

Exposure Based Review:

Health: No

Ecotox: No

Routes of exposure: Health: Dermal Drinking Water Inhalation 

Ecotox: All releases to water

Fate: ;

Keywords:

 Keywords: 

IRR-S,L,MM

LIVER

KIDNEY

NEURO

DEVEL

SENS-S,L

MUTA

MARG ONCO

AQUATOX-A,C

Summary of Assessment:

 Fate:

Fate Summary: P-13-0055-56

FATE: Estimations for low weight 
Liquid with MP < 25 C (E)

log Kow = 2.43 (E) 

S = 1.17 g/L at 25 C (E)

VP = 6.2E-2 torr at 25 C (E)

BP = 220 C (E)

H = 3.71E-7 (E)

log Koc = 2.44 (E)

log Fish BCF = 1.27 (E)

log Fish BAF = 0.91 (E) 

POTW removal (%) = 0-25 

Time for complete ultimate aerobic biodeg = wk

Sorption to soils/sediments = low

Volatilization half-life from a standard river = 1000 hrs

Volatilization half-life from a standard lake = 820 da

Atmospheric Oxidation Half-life = 6.0 hr via OH radical

PBT Potential: P1B1

*CEB FATE: Migration to ground water = moderate - rapid

 Health:

 Health Summary: Absorption is moderate all routes, based on anlogs. 

Expect the PMN substance to be an alkylating agent to the extent the 

substituent is present There are concerns for irritation to all exposed tissues, adverse effects to 

the liver and kidney, neurotoxicity, and sensitization, based on analogs (similarities to ) 

and information in the PMN MSDS. There also is concern for developmental toxicity based on 

. There also are concerns for skin and lung sensitization, mutagenicity, and 

developmental, liver, and kidney toxicities, as well as marginal concern for oncogenicity and 

uncertain concern for irritation, based on alkylation potentials.

 Ecotox:

Test Organism Test 

Type

Test End 

Point

Predicted Measured Comments

fish 96-h LC50 4.0 2.6 Analog-CASRN 

daphnid 48-h LC50 11.3 16 Analog-CASRN 

green algal 96-h EC50 0.015 0.018 Analog-CASRN 

fish _ chronic value 1.0 0.17 Analog-CASRN 

daphnid _ chronic 

value

3.5 1.8 Analog-CASRN 

algal _ chronic 

value

0.003 0.004 Analog-CASRN 

Sewage Sludge 3-h EC50 _
Sewage Sludge _ Chronic 

Value

_

Ecotox Values Comments: Predictions are based on SARs for ; SAR 

chemical class = ; MW 128; liquid (P); S = 1,170 mg/L at 20 °C (P); pH7; 

effective concentrations based on 100% active ingredients and measured concentrations; 

hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments

Assessment Factor 10

Concentration of Concern 

(ppb)

1

SARs

SAR Class

Ecotox Category 

Ecotox Factors Comments: 

 SAT Chair: J. Kwiat
<TABLE> <S> <C>

<ARTICLE>               7
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<DEBT-HELD-FOR-SALE>                        15,317,281
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                     221,323
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                              15,538,604
<CASH>                                       2,671,562
<RECOVER-REINSURE>                           3,373,983
<DEFERRED-ACQUISITION>                       1,164,044
<TOTAL-ASSETS>                              32,674,810
<POLICY-LOSSES>                             13,565,719
<UNEARNED-PREMIUMS>                          7,652,118
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                      0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     3,049,089
<OTHER-SE>                                   6,682,110
<TOTAL-LIABILITY-AND-EQUITY>                32,674,810
<PREMIUMS>                                   5,336,633
<INVESTMENT-INCOME>                            448,417
<INVESTMENT-GAINS>                              33,316
<OTHER-INCOME>                                       0
<BENEFITS>                                   4,052,800
<UNDERWRITING-AMORTIZATION>                  2,189,355
<UNDERWRITING-OTHER>                                 0
<INCOME-PRETAX>                              (423,789)
<INCOME-TAX>                                 (155,416)
<INCOME-CONTINUING>                          (268,373)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (268,373)
<EPS-PRIMARY>                                   (0.09)
<EPS-DILUTED>                                   (0.09)
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>